Advisors Asset Management’s Medifast MED Stock Holding History

Advisors Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.74K	Sell	269 -34	-11%	-$367	﹤0.01%	1420
2025 Q4	$3.24K	Sell	303 -3	-1%	-$36	﹤0.01%	1396
2025 Q3	$4.18K	Sell	306 -2,618	-90%	-$36.6K	﹤0.01%	1402
2025 Q2	$41.1K	Sell	2,924 -3,075	-51%	-$40.4K	﹤0.01%	1298
2025 Q1	$80.9K	Sell	5,999 -2,306	-28%	-$34.6K	﹤0.01%	1234
2024 Q4	$146K	Sell	8,305 -1,129	-12%	-$21K	﹤0.01%	1161
2024 Q3	$181K	Sell	9,434 -159	-2%	-$3.06K	﹤0.01%	1119
2024 Q2	$209K	Sell	9,593 -17,479	-65%	-$466K	﹤0.01%	1091
2024 Q1	$1.04M	Sell	27,072 -20,255	-43%	-$981K	0.02%	731
2023 Q4	$3.18M	Sell	47,327 -181	-0.4%	-$12.6K	0.07%	377
2023 Q3	$3.56M	Buy	47,508 +3,931	+9%	+$349K	0.08%	340
2023 Q2	$4.02M	Buy	43,577 +7,784	+22%	+$693K	0.08%	307
2023 Q1	$3.71M	Buy	35,793 +22,088	+161%	+$2.45M	0.08%	324
2022 Q4	$1.58M	Buy	13,705 +12,552	+1,089%	+$1.46M	0.03%	580
2022 Q3	$125K	Sell	1,153 -55	-5%	-$7.88K	﹤0.01%	1225
2022 Q2	$218K	Sell	1,208 -30	-2%	-$5.37K	﹤0.01%	1148
2022 Q1	$211K	Sell	1,238 -40	-3%	-$7.54K	﹤0.01%	1217
2021 Q4	$268K	Buy	1,278 +327	+34%	+$67.6K	﹤0.01%	1166
2021 Q3	$183K	Buy	951 +581	+157%	+$143K	﹤0.01%	1225
2021 Q2	$105K	Buy	+370	New	+$100K	﹤0.01%	1299

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Advisors Asset Management's MED Position: Q1 2026 in Review

Advisors Asset Management reduced its Medifast (MED) stake by 11% in Q1 2026, selling an estimated $367 and leaving 269 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Advisors Asset Management first reported a position in MED in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.02M in Q2 2023. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

Advisors Asset Management held 269 shares of Medifast worth $2.74K as of Q1 2026.
Advisors Asset Management sold 34 Medifast shares in Q1 2026, an estimated $367.
Medifast made up ﹤0.01% of Advisors Asset Management's portfolio in Q1 2026, its #1420 holding.
Advisors Asset Management first reported a position in Medifast in Q2 2021 and has held it in 20 quarters since.
Advisors Asset Management's Medifast position peaked at $4.02M in Q2 2023.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.